Locust Wood Capital Advisers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$127M Buy
325,825
+654
+0.2% +$254K 3.38% 10
2025
Q1
$141M Buy
325,171
+68,128
+27% +$29.6M 4.48% 6
2024
Q4
$94.8M Buy
257,043
+18,598
+8% +$6.86M 3.27% 14
2024
Q3
$124M Sell
238,445
-60,961
-20% -$31.7M 4.14% 6
2024
Q2
$162M Buy
299,406
+9,592
+3% +$5.2M 5.81% 3
2024
Q1
$150M Buy
289,814
+3,745
+1% +$1.94M 5.38% 3
2023
Q4
$135M Buy
286,069
+108,814
+61% +$51.3M 5.12% 3
2023
Q3
$77.2M Sell
177,255
-55,680
-24% -$24.2M 3.28% 12
2023
Q2
$103M Buy
232,935
+23,343
+11% +$10.4M 4.81% 3
2023
Q1
$96.4M Buy
209,592
+51,367
+32% +$23.6M 5.64% 2
2022
Q4
$81.2M Buy
158,225
+3,270
+2% +$1.68M 4.55% 3
2022
Q3
$70.4M Buy
154,955
+14,617
+10% +$6.64M 4.86% 2
2022
Q2
$67.7M Sell
140,338
-64,272
-31% -$31M 4.19% 5
2022
Q1
$101M Buy
204,610
+42,062
+26% +$20.7M 5.51% 2
2021
Q4
$75.3M Buy
162,548
+38,152
+31% +$17.7M 3.77% 4
2021
Q3
$46.4M Buy
124,396
+2,187
+2% +$815K 2.52% 17
2021
Q2
$46.7M Buy
122,209
+4,822
+4% +$1.84M 2.68% 18
2021
Q1
$42.1M Buy
117,387
+5,339
+5% +$1.92M 2.48% 18
2020
Q4
$36M Buy
112,048
+17,060
+18% +$5.48M 2.05% 17
2020
Q3
$25.5M Sell
94,988
-77,915
-45% -$20.9M 1.65% 23
2020
Q2
$45.5M Buy
172,903
+80,000
+86% +$21M 2.82% 7
2020
Q1
$21.1M Sell
92,903
-80,872
-47% -$18.4M 1.78% 21
2019
Q4
$52.5M Buy
173,775
+14,055
+9% +$4.25M 3.89% 4
2019
Q3
$38.3M Sell
159,720
-23,614
-13% -$5.67M 3.24% 10
2019
Q2
$51.7M Sell
183,334
-6,240
-3% -$1.76M 3.82% 6
2019
Q1
$54.4M Buy
189,574
+72,814
+62% +$20.9M 4.25% 5
2018
Q4
$30.7M Buy
116,760
+51,325
+78% +$13.5M 2.36% 12
2018
Q3
$17.9M Buy
+65,435
New +$17.9M 1.24% 25